|
IONS | Ionis Pharmaceuticals Inc |
|
|
IONS | Ionis Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.06 |
| Leverage | 78.84% |
| Market Cap | $ 10.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -266.7m |
| Margin | -28.26% |
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.